1. Home
  2. APGE vs BCPC Comparison

APGE vs BCPC Comparison

Compare APGE & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$132.71

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Balchem Corporation

BCPC

Balchem Corporation

HOLD

Current Price

$168.99

Market Cap

5.6B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
APGE
BCPC
Founded
2022
1967
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
5.6B
IPO Year
2023
1995

Fundamental Metrics

Financial Performance
Metric
APGE
BCPC
Price
$132.71
$168.99
Analyst Decision
Strong Buy
Buy
Analyst Count
13
2
Target Price
$109.67
$176.00
AVG Volume (30 Days)
4.0M
202.3K
Earning Date
05-12-2026
04-30-2026
Dividend Yield
N/A
0.55%
EPS Growth
N/A
20.87
EPS
N/A
1.25
Revenue
N/A
$799,023,000.00
Revenue This Year
N/A
$8.47
Revenue Next Year
N/A
$4.89
P/E Ratio
N/A
$132.83
Revenue Growth
N/A
13.56
52 Week Low
$34.34
$139.17
52 Week High
$133.16
$183.90

Technical Indicators

Market Signals
Indicator
APGE
BCPC
Relative Strength Index (RSI) 81.42 65.60
Support Level $75.41 $167.19
Resistance Level N/A $171.50
Average True Range (ATR) 4.21 3.07
MACD 5.57 0.97
Stochastic Oscillator 99.15 87.20

Price Performance

Historical Comparison
APGE
BCPC

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: